Product peptide-Inhibitory-peptide

Home > products > peptide> Inhibitory-peptide

Catalog	name	Description	price
R-R-0977	Elabela(19-32)	Elabela(19-32)/CAS No.1886973-05-2 is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart.	price>
R-R-0988	Ac-DEVD-CHO	Ac-DEVD-CHO/CAS No.169332-60-9 is a chemical compound used in research and drug development. It is an inhibitor of caspase enzymes, particularly caspase-3, which plays a crucial role in programmed cell death (apoptosis). The compound is designed to irreversibly bind to the active site of the enzyme, inhibiting its function and preventing programmed cell death from occurring. Ac-DEVD-CHO is often used in studies to better understand the mechanisms of apoptosis and to develop potential therapeutic interventions for diseases where apoptosis regulation plays a critical role, such as cancer and neurodegenerative disorders.	price>
R-R-1001	N-Nonyldeoxynojirimycin	N-Nonyldeoxynojirimycin (NN-DNJ)/CAS No.81117-35-3 is a potent inhibitor of alpha-glucosidase and alpha-1,6-glucosidase (IC50s, 0.42, 8.4 μM, respectively), inhibits glycogen breakdown.	price>
R-R-1004	JMV 449 acetate	JMV 449 acetate/CAS No.141863-45-8 is a potent neurotensin receptor agonist. JMV 449 acetate shows an IC50 of 0.15 nM for inhibition of 125I-neurotensin binding to neonatal mouse brain and an EC50 of 1.9 nM in contracting the guinea-pig ileum. JMV 449 acetate has highly potent and long-lasting hypothermic and analgesic effects in the mouse.	price>
R-R-1005	Actinomycin X2	Actinomycin X2 (Actinomycin V)/CAS No.18865-48-0, produced by many Streptomyces sp., shows strong inhibition of MRSA with a minimum inhibitory concentration (MIC) value of 0.25 μg/mL. Actinomycin X2 can be used for cancer and bacterial infection.	price>
R-R-1016	(Ala13)-Apelin-13 TFA	(Ala13)-Apelin-13 TFA is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 TFA inhibits gastric motility through vagal cholinergic pathway.	price>
R-R-1018	KKI-5 TFA	KKI-5 (TFA) is a specific inhibitor of tissue kallikrein. KKI-5 (TFA) can attenuate breast cancer cell invasion.The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.	price>
R-R-1026	Reltecimod TFA	Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs).	price>
R-R-1027	Antagonist G	Antagonist G/CAS No.115150-59-9 is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.	price>
R-R-1032	Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA	Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)/CAS No.199807-33-5 is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia.	price>

...